CyMeda's Management Team

Mr. Irwin brings over four decades of management and product development experience to the founding team. Prior to his six years as CEO of CyMeda, Inc, Mr. Irwin was co-founder, Chairman, CEO, and CTO of Ra Medical Systems, Inc. (NYSE:RMED) from 2002 to 2019 where he invented the Pharos dermatological system and the DABRA Vascular system. He took the company to IPO in the NYSE big board in 2018. Prior to that he was the Vice President of Research & Development and V.P. of Engineering for PhotoMedex (NASDAQ:PHMD), where he invented laser systems for cardiovascular surgery and dermatology, including the XTRAC. Prior to his tenure at PhotoMedex, Mr. Irwin was Vice President of Engineering and General Manager at Spatialight, Inc. (NASDAQ:HDTV) where he developed award-winning electro-optical components and systems. Mr. Irwin was also a founder and chief scientist of DIR Corporation and has held various engineering positions with Acculase, General Atomics, and Universal Voltronics Corporation. In addition, he has consulted for the Plasma Research Center at the Massachusetts Institute of Technology (MIT), the Institute of Plasma Physics at Nagoya University in Japan, Borland International, and Intel Corporation. Mr. Irwin has been issued twenty-nine patents in the field of electro-optics, and has published numerous engineering and scientific papers. He has also authored and received FDA 510(k) clearances, KFDA (Korea), CFDA (China), and CE (EU) mark. He has run several successful clinical trials to support FDA acceptance, both PMA and 510(k)s.

https://www.linkedin.com/in/dean-irwin-baa54416

Ms. Chester joined CyMeda in October 2022, bringing over 25 years of experience in the high-tech medical device sector, with a strong focus on medical lasers. She joined the industry in 1999 at PhotoMedex, where she held progressively responsible roles in the regulatory group. After serving as the regulatory affairs manager at Epitope Diagnostics, an IVD manufacturer, she joined Ra Medical Systems in 2013. During her time there, she held several key management positions in quality assurance and regulatory affairs. She was instrumental in achieving and maintaining regulatory compliance, driven by her commitment to bringing safe and effective medical devices to market. She oversaw multiple audits by FDA, the State of California, and ISO notified bodies. She also was a key member of the clinical and regulatory team completing Ra Medical’s pivotal study. Ms. Chester holds a Bachelor of Science in Chemistry from Bradley University. https://www.linkedin.com/in/vickichester/

Mr. Schmidt brings over 30 years of expertise in the medical device manufacturing industry, having held key leadership and engineering roles throughout his career. He is currently the Director of Operations for CyMeda, Inc. He began as a Manufacturing Engineer at Mentor Corporation, where he gained foundational experience in medical device production. Over the years, he has contributed to the success of prominent companies including Safeskin Corporation and PhotoMedex, Inc. Most recently, Mr. Schmidt served as Director of Operations at Ra Medical, overseeing critical operational strategies and manufacturing processes. He holds a Bachelor of Science in Chemical Engineering from the University of California, Santa Barbara.

https://www.linkedin.com/in/bill-schmidt-0991156/

Prior to CyMeda, Ms. Burstein co-founded Ra Medical and served as its Executive Vice President, Secretary, and a Director from September 2002 to 2019. During her tenure, Ms. Burstein scaled the organization from startup through its IPO (NYSE: RMED), supporting multiple product launches and growth to a 140-person team. Prior to Ra Medical, Ms. Burstein led product launches and marketing initiatives at Eli Lilly (Lilly) and Amylin Pharmaceuticals (acquired by Bristol-Myers Squibb), developing patient and professional communications within regulated healthcare environments. She specializes in translating complex clinical and technical concepts into clear, compelling messaging that resonates with target audiences and delivers results across U.S. and international markets. Ms. Burstein holds an MBA specializing in international management from Thunderbird, the American Graduate School of International Management, and a B.S. from Georgetown University.

https://www.linkedin.com/in/melissaburstein/